Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women
- PMID: 21216869
- PMCID: PMC3071227
- DOI: 10.1093/infdis/jiq083
Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women
Abstract
Background: It is well established that the prevalence of human papillomavirus (HPV) infection is increased among human immunodeficiency virus (HIV)-positive individuals, but the temporal relationships between these infections are unclear.
Methods: During a South African cervical cancer screening trial, 5595 women 35-65 years of age were followed up for 36 months; 577 women were HIV positive at enrollment, HIV seroconversion occurred in 123 women, and 4895 women remained HIV negative throughout. Tests for high-risk HPV DNA and cytology were performed on cervical samples, and a colposcopy/biopsy was performed at each visit. The effects of early HIV infection on the risk of HPV infection and HPV-related disease were evaluated.
Results: Among seroconverters, HPV infection prevalence was 20.3% before seroconversion, 23.6% at seroconversion (P = .4), and 49.1% after seroconversion (P = .01). Seroconverters had significantly lower HPV infection prevalence than women with prevalent HIV infection before and at seroconversion (41.8% and 45.9%, respectively) but had similar HPV infection prevalence to women with prevalent HIV infection after seroconversion (49.4%). HIV seroconversion was associated with newly detected HPV infection (adjusted hazard ratio [AHR], 4.02; 95% confidence interval [CI], 2.26-7.13) and increased risk of low-grade cytological abnormalities (AHR, 2.53; 95% CI, 1.16-5.51) compared with HIV-negative women.
Conclusion: Detection of HPV infection increases rapidly within the first years after HIV seroconversion, suggesting that mucosal immune dysfunction occurring at an early stage of HIV infection may influence HPV-related diseases.
Figures
Similar articles
-
Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women.Int J Cancer. 2007 Dec 1;121(11):2484-91. doi: 10.1002/ijc.22947. Int J Cancer. 2007. PMID: 17683070
-
Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status.BMC Infect Dis. 2015 Oct 26;15:459. doi: 10.1186/s12879-015-1181-8. BMC Infect Dis. 2015. PMID: 26502723 Free PMC article.
-
HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.AIDS. 1996 Apr;10(4):413-7. doi: 10.1097/00002030-199604000-00010. AIDS. 1996. PMID: 8728046
-
Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women.J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):162-8. doi: 10.1097/QAI.0000000000000428. J Acquir Immune Defic Syndr. 2015. PMID: 25394189
-
HPV and the Risk of HIV Acquisition in Women.Front Cell Infect Microbiol. 2022 Feb 10;12:814948. doi: 10.3389/fcimb.2022.814948. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35223546 Free PMC article. Review.
Cited by
-
Brugia malayi Antigen (BmA) Inhibits HIV-1 Trans-Infection but Neither BmA nor ES-62 Alter HIV-1 Infectivity of DC Induced CD4+ Th-Cells.PLoS One. 2016 Jan 25;11(1):e0146527. doi: 10.1371/journal.pone.0146527. eCollection 2016. PLoS One. 2016. PMID: 26808476 Free PMC article.
-
Persistence of oncogenic and non-oncogenic human papillomavirus is associated with human immunodeficiency virus infection in Kenyan women.SAGE Open Med. 2020 Jul 28;8:2050312120945138. doi: 10.1177/2050312120945138. eCollection 2020. SAGE Open Med. 2020. PMID: 32782796 Free PMC article.
-
Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination.J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):390-9. doi: 10.1097/QAI.0b013e3182676fe3. J Acquir Immune Defic Syndr. 2012. PMID: 22820809 Free PMC article.
-
Cervical Abnormalities in South African Women Living With HIV With High Screening and Referral Rates.J Glob Oncol. 2016 May 4;2(6):375-380. doi: 10.1200/JGO.2015.002469. eCollection 2016 Dec. J Glob Oncol. 2016. PMID: 28717723 Free PMC article.
-
Cervical HPV infection in Romanian women infected with HIV during early childhood.Int J STD AIDS. 2016 Oct;27(12):1079-1085. doi: 10.1177/0956462415608333. Epub 2015 Sep 24. Int J STD AIDS. 2016. PMID: 26404111 Free PMC article.
References
-
- De Vuyst H, Lillo F, Broutet N, Smith JS. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev. 2008;17:545–54. - PubMed
-
- Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC., Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med. 1997;337:1343–9. - PubMed
-
- Palefsky JM, Minkoff H, Kalish LA, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive high-risk HIV-negative women. J Natl Cancer Inst. 1999;91:226–36. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical